Earnings Feed
Start Free
Talon Therapeutics, Inc.·4

Jan 10, 9:57 PM ET

GONZALO CECILIA 4

4 · Talon Therapeutics, Inc. · Filed Jan 10, 2012

Insider Transaction Report

Form 4
Period: 2012-01-09
Talon Therapeutics, Inc.TLON
GONZALO CECILIA
Director
Transactions
  • Award

    Series A-2 Convertible Preferred Stock, $0.001 Par Value

    2012-01-09$100.00/sh+99,000$9,900,000→ 99,000 total(indirect: See Footnotes)
    Exercise: $0.30From: 2012-01-09→ Common Stock (33,000,000 underlying)
  • Award

    Right to acquire Series A-3 Convertible Preferred Stock

    2012-01-09+1→ 1 total(indirect: See Footnotes)
    Exercise: $100.00From: 2012-01-09→ Series A-3 Convertible Preferred Stock, $0.001 Par Value (600,000 underlying)
Footnotes (4)
  • [F1]See Exhibit 99.1, Note 1.
  • [F2]See Exhibit 99.1, Note 2.
  • [F3]See Exhibit 99.1, Note 3.
  • [F4]See Exhibit 99.1, Note 4.

Documents

2 files